^
+ Follow Xeloda Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 162433
                    [Title] => ‘Smart tablet’ effective in cancers
                    [Summary] => Data presented at the recent 38th annual meeting of the American Society for Clinical Oncology (ASCO) showed that Xeloda (capecitabine), Roche’s new oral tumor-activated chemotherapy treatment, is highly effective at treating gastrointestinal cancers – colorectal, stomach and oesophageal. 


Various study results presented at the ASCO meeting showed that the oral Xeloda has the potential to effectively replace the current standard treatment, intravenous (iv) 5-FU, in gastrointestinal cancers.
[DatePublished] => 2002-05-27 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
Xeloda
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 162433
                    [Title] => ‘Smart tablet’ effective in cancers
                    [Summary] => Data presented at the recent 38th annual meeting of the American Society for Clinical Oncology (ASCO) showed that Xeloda (capecitabine), Roche’s new oral tumor-activated chemotherapy treatment, is highly effective at treating gastrointestinal cancers – colorectal, stomach and oesophageal. 


Various study results presented at the ASCO meeting showed that the oral Xeloda has the potential to effectively replace the current standard treatment, intravenous (iv) 5-FU, in gastrointestinal cancers.
[DatePublished] => 2002-05-27 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with